Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. The firm's solutions enable pharmaceutical and other life sciences companies to realize ...

Veeva Systems (VEEV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Veeva Systems has produced solid returns since it became public. The company is facing some challenges, notably increased competition. The cloud specialist's strong moat and large addressable market ...

Veeva Systems, which offers life sciences companies cloud-based commercial management software and business consulting services, is venturing into the consumer-facing side of things with the ...

PLEASANTON, Calif., March 10, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the acquisition of Ostro, the leading brand engagement platform for life sciences that gives patients and ...

As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for domination of big pharma CRM, it began the first massive use case for adoption of ...

Veeva Systems (NYSE: VEEV) is currently in Phase 18, the final stage of its 18-phase Adhishthana cycle on the weekly charts. The company recently reported earnings, and the stock has fallen sharply ...

Veeva Systems Inc. (NYSE:VEEV) is one of the best digital health stocks to buy now. On November 4, 2025, Veeva announced that its Veeva Basics solution has been adopted by “more than 100 biotechs” to ...

Veeva Systems Inc. (NYSE:VEEV) reported better-than-expected earnings for the second quarter on Wednesday. The company posted quarterly earnings of $1.99 per share which beat the analyst consensus ...

The yearslong legal kerfuffle between IQVIA and Veeva Systems has come to a close, with the former adversaries setting aside their differences to launch a series of clinical and commercial ...